Targeted treatment Perjeta (pertuzumab) gets regulatory green light in UK for use in

[News]

Perjeta regimen nearly doubled number of women whose tumours are eradicated versus standard treatmentOver 1,800 women per year in the UK2 with an aggressive type of breast cancer could...

More... (http://www.medicalnewstoday.com/releases/300180.php)